Regeneron antibody cocktail cuts risk of Covid hospitalization or death 70% | Daily Mail Online
Both doses of Regeneron's coronavirus antibody cocktail were found to reduce the risk of hospitalization or death by about 70% compared to a placebo, new trial data revealed.
https://www.dailymail.co.uk/health/article-9393693/Regenerons-antibody-cocktail-cuts-risk-hospitalization-death-COVID-19-70.html